Serif Senturk
Serif Senturk
Research Group Leader at Izmir Biomedicine and Genome Center
Verified email at - Homepage
Cited by
Cited by
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ...
autophagy 17 (1), 1-382, 2021
Canonical Wnt signaling is antagonized by noncanonical Wnt5a in hepatocellular carcinoma cells
H Yuzugullu, K Benhaj, N Ozturk, S Senturk, E Celik, A Toylu, N Tasdemir, ...
Molecular Cancer 8 (1), 1, 2009
Transforming growth factor‐beta induces senescence in hepatocellular carcinoma cells and inhibits tumor growth
S Senturk, M Mumcuoglu, O Gursoy‐Yuzugullu, B Cingoz, KC Akcali, ...
Hepatology 52 (3), 966-974, 2010
Senescence and immortality in hepatocellular carcinoma
M Ozturk, A Arslan-Ergul, S Bagislar, S Senturk, H Yuzugullu
Cancer Letters 286 (1), 103-113, 2009
Rapid and tunable method to temporally control gene editing based on conditional Cas9 stabilization
S Senturk, NH Shirole, DG Nowak, V Corbo, D Pal, A Vaughan, ...
Nature Communications 8 (1), 1-10, 2017
Reprogramming of replicative senescence in hepatocellular carcinoma-derived cells
N Ozturk, E Erdal, M Mumcuoglu, KC Akcali, O Yalcin, S Senturk, ...
PNAS 103 (7), 2178-2183, 2006
p53Ψ is a transcriptionally inactive p53 isoform able to reprogram cells toward a metastatic-like state
S Senturk, Z Yao, M Camiolo, B Stiles, T Rathod, AM Walsh, ...
PNAS 111 (32), E3287-E3296, 2014
Inhibition of Akt signaling in hepatoma cells induces apoptotic cell death independent of Akt activation status
F Buontempo, T Ersahin, S Missiroli, S Senturk, D Etro, M Ozturk, ...
Investigational new drugs 29 (6), 1303-1313, 2011
MYC drives Pten/Trp53-deficient proliferation and metastasis due to IL6 secretion and AKT suppression via PHLPP2
DG Nowak, H Cho, T Herzka, K Watrud, DV DeMarco, VMY Wang, ...
Cancer discovery 5 (6), 636-651, 2015
Guidelines for the use and interpretation of assays for monitoring autophagy 1
DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ...
Autophagy 17 (1), 1-382, 2021
TP53 exon-6 truncating mutations produce separation of function isoforms with pro-tumorigenic functions
NH Shirole, D Pal, ER Kastenhuber, S Senturk, J Boroda, P Pisterzi, ...
Elife 5, e17929, 2016
Imetelstat (a telomerase antagonist) exerts off‑target effects on the cytoskeleton
I Mender, S Senturk, N Ozgunes, K Akcali, D Kletsas, S Gryaznov, A Can, ...
International Journal of Oncology 42 (5), 1709-1715, 2013
The ability to generate senescent progeny as a mechanism underlying breast cancer cell heterogeneity
M Mumcuoglu, S Bagislar, H Yuzugullu, H Alotaibi, S Senturk, ...
PloS one 5 (6), e11288, 2010
Next-generation liver medicine using organoid models
S Akbari, N Arslan, S Senturk, E Erdal
Frontiers in Cell and Developmental Biology 7, 345, 2019
Thioredoxin interacting protein promotes invasion in hepatocellular carcinoma
A Gunes, E Bagirsakci, E Iscan, G Cakan-Akdogan, U Aykutlu, S Senturk, ...
Oncotarget 9 (96), 36849, 2018
Genomics and functional genomics of malignant pleural mesothelioma
E Cakiroglu, S Senturk
International Journal of Molecular Sciences 21 (17), 6342, 2020
The Jekyll and Hyde of Cellular Senescence in Cancer
D Demirci, B Dayanc, FA Mazi, S Senturk
Cells 10 (2), 208, 2021
A rapid and tunable method to temporally control Cas9 expression enables the identification of essential genes and the interrogation of functional gene interactions in vitro …
S Senturk, NH Shirole, DD Nowak, V Corbo, A Vaughan, DA Tuveson, ...
BioRxiv, 023366, 2015
Retinoic acid signaling and bladder cancer: Epigenetic deregulation, therapy and beyond
G Ozgun, S Senturk, S Erkek‐Ozhan
International Journal of Cancer 148 (10), 2364-2374, 2021
Special Focus Issue Part II: Recruitment of solid lipid nanoparticles for the delivery of CRISPR/Cas9: primary evaluation of anticancer gene editing
H Akbaba, G Erel-Akbaba, S Senturk
Nanomedicine 16 (12), 963-978, 2021
The system can't perform the operation now. Try again later.
Articles 1–20